Nanjing Hicin Pharmaceutical Co Ltd (300584) — Long-term Investment Intensity
Nanjing Hicin Pharmaceutical Co Ltd (300584) has a Long-term Investment Intensity of 15.7% as of September 2019. Long-term investments of CN¥130.28 Million represent 15.7% of total assets of CN¥830.51 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 300584 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Nanjing Hicin Pharmaceutical Co Ltd Long-term Investment Intensity (2017–2018)
This chart shows how Nanjing Hicin Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2017 to 2018. As of September 2019, the intensity stands at 15.7%, reflecting long-term investments of CN¥130.28 Million against total assets of CN¥830.51 Million CNY. Explore Nanjing Hicin Pharmaceutical Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Nanjing Hicin Pharmaceutical Co Ltd (2017–2018)
The table below presents the year-by-year Long-term Investment Intensity for Nanjing Hicin Pharmaceutical Co Ltd from 2017 to 2018, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 300584 stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 16.4% | CN¥130.28 Million | CN¥794.19 Million | ▲ +16.3 pp |
| 2017 | 0.1% | CN¥800.00K | CN¥632.30 Million | — |